Clinical Trials Logo

Adenocarcinoma, Renal Cell clinical trials

View clinical trials related to Adenocarcinoma, Renal Cell.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00719264 Completed - Clinical trials for Carcinoma, Renal Cell

Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer

Start date: November 2008
Phase: Phase 2
Study type: Interventional

To estimate the difference in efficacy and safety of bevacizumab and RAD001 compared to bevacizumab and interferon alfa-2a for first-line treatment of patients with metastatic carcinoma of the kidney.

NCT ID: NCT00059735 Completed - Clinical trials for Carcinoma, Renal Cell

A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma

Start date: May 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if E7070 is a safe and effective treatment for cancer of the kidneys.